Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$1.7B
Avg Funding
$66.7M
Cities
18

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Chatswood, Australia
$807K
raised

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$100.0M
raised

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$3.8M
raised

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malvern, United States
$1.9M
raised

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$25.0M
raised

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Woburn, United States
$4.1M
raised

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fremont, United States
$1.8M
raised

ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$60.0M
raised

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alameda, United States
$36.0M
raised

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$212.0M
raised

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Berkeley, United States
$125.0M
raised

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$25.5M
raised

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$3.6M
raised

Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Austin, United States
$210.0M
raised

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mountain View, United States
$107.3M
raised

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$235.5M
raised

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$564K
raised

Pioneering advanced cancer diagnostics and regenerative medicine treatments.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Marlborough, United States
$43.5M
raised

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$74.2M
raised

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$67.8M
raised

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$160.0M
raised

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$40.0M
raised

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 401 to 425 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 17 | VCBacked